TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $10,000 | -9.1% | 1,000 | 0.0% | 0.00% | -25.0% |
Q1 2021 | $11,000 | -26.7% | 1,000 | 0.0% | 0.00% | -20.0% |
Q4 2020 | $15,000 | +7.1% | 1,000 | 0.0% | 0.01% | -16.7% |
Q3 2020 | $14,000 | +75.0% | 1,000 | 0.0% | 0.01% | +200.0% |
Q2 2020 | $8,000 | +100.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $4,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
Artal Group S.A. | 150,000 | $870,000 | 0.02% |
Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |